Table 1 Lung function data of the control period (jet nebuliser) and the study period (eFlow® rapid), n = 59; Values are median (range)
From: Lung function in adult patients with cystic fibrosis after using the eFlow® rapid for one year
Control period | Jet Nebuliser | Mean difference | P | |
|---|---|---|---|---|
T1 | T2 | (T1 - T2) | ||
FEV1 [%] | 67.2 | 64.1 | -3.1% | |
(26.2-136.4) | (27.6-130.1) | |||
FVC [%] | 88.3 | 89.4 | + 1.1% | |
(43.2-145) | (44.4-142.1) | |||
PEF [%] | 63.6 | 65.0 | +1.4% | |
(18.6-109.7) | (23.2-108.3) | |||
MEF 25[%] | 15.6 | 13.0 | -2.6% | |
(0.0-101.3) | (3.0-89.0) | |||
Study period | eFlow ® rapid | Mean difference | P | |
T3 | T4 | (T3 - T4) | ||
FEV1 [%] | 65.0 | 63.6 | -1.4% | |
(24.0-131.0) | (222.0-131.6) | |||
FVC [%] | 86.0 | 88.9 | +2.9% | |
(42.9-151.4) | (30.9-151.0) | |||
PEF [%] | 62.4 | 59.5 | -2.9% | |
(17.1-113.2) | (13.9-122.2) | |||
MEF25 [%] | 16.0 | 14.4 | -1.6% | |
(0.0-278) | (2.8-78.2) | |||